Delivery Order SPE2DB22D3301-SPE2DB26FX4HH
- Not listed
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets in quantities of 100 units, with a contract ceiling value of $27,644.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $3,804.24 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S, a antimalarial pharmaceutical product. The award, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, was made on a firm fixed-price basis without a set-aside designation, indicating competitive award through open competition. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,508.34 to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by the Department of Defense for malaria prophylaxis in military personnel. This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $8,479.30 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 in quantities of 100 units. The contract, awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $33,579 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 in a quantity of 100 units. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of September 17, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract ceiling value of $3,665.97. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for May 21, 2025, and performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This delivery order, awarded November 6, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 100 units of Atovaquone-Proguanil 250-100 medication with a ceiling value of $11,193.00 and a firm fixed price structure. The order is scheduled for completion by November 7, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,947.11 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 100S, a combination antimalarial medication commonly used for malaria prophylaxis and treatment by military personnel. This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4HHDelivery Order
The Defense Logistics Agency awarded a $9,457.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Atovaquone-Proguanil 250-100 100S, a antimalarial pharmaceutical product. The delivery order is non-set-aside and was competitively awarded, with an ultimate completion date of November 5, 2025. Performance of this contract will take place at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. The parent contract serves as a critical supply mechanism for military and federal healthcare systems, enabling the delivery of an extensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 11/4/25 |